MESI

31/03/2026

Compression therapy starts with confidence in arterial status.

At EWMA-DEWU 2026, MESI will showcase how fast, automated ABI and TBI assessment can support safer treatment decisions in wound care practice.

With the MESI mTABLET, clinicians can perform a 1-minute arterial assessment, helping evaluate vascular status quickly and efficiently before compression therapy.

📅 6–8 May 2026
📍 Bremen
📍 Booth E-50

If you're attending EWMA, we warmly invite you to stop by and discover how Integrated Diagnostics can support vascular assessment in everyday care.

🤝 Book a meeting: https://hubs.ly/Q048_b6s0

30/03/2026

Spirometry made easy

Early detection of respiratory issues is key to better outcomes. With the MESI mTABLET spirometry module, clinicians can perform fast, reliable lung function tests, right at the point of care.

✔ Automated, guided testing
✔ Always ready, always accurate
✔ Detailed reports with automatic bronchodilation % difference calculation

MESI mTABLET SPIRO transforms respiratory assessment with a fully digital workflow, so you can act faster, standardize testing, and work more efficiently. Discover how it can support your practice:
👉 https://hubs.ly/Q048BbLd0

30/03/2026

Selling Integrated Diagnostics takes more than product knowledge.

At MESI Conference 2026, the Sales Skills Lab is designed to help partners strengthen the way they communicate value, handle pricing conversations and turn real-world challenges into successful sales discussions.

From value, story and structure to objections, upselling and conversion tactics, this is where commercial confidence gets sharper.

Because stronger markets are built through stronger conversations.

📍 Bled, Slovenia
📅 18–19 May 2026
Register here: https://hubs.ly/Q048zDDy0

29/03/2026

Integrated Diagnostics Reshaping How Care is Delivered

We spoke with Dr Hüseyin Kılıçaslan, Director of Remote Health Services at OneDose, whose 25+ years of experience span public healthcare and health system management. Today, he focuses on advancing remote healthcare through Integrated Diagnostic solutions, now essential in modern clinical practice.

As Dr Kılıçaslan puts it: “A single piece of data indicates a situation, but data obtained consecutively shows the direction.”

Together, MESI and OneDose demonstrate how Integrated Diagnostic solutions empower healthcare providers with clearer direction and improved patient care.

🎧 Listen to this episode of mTALK for more insights https://hubs.ly/Q048zK690

We spoke with Dr Hüseyin Kılıçaslan, Director of Remote Health Services at OneDose, whose 25+ years of experience span public healthcare and health system management. Today, he focuses on advancing remote healthcare through Integrated Diagnostic solutions, now essential in modern clinical practi...

28/03/2026

All Core Measurements. One device.

MESI mTABLET combines all core diagnostic measurements - ABI, TBI, ECG, spirometry, blood pressure, Vitals, and more - into a single wireless platform.

Each module connects instantly and works seamlessly together, helping you reduce complexity and perform faster exams from one interface. Add new modules as your needs evolve, with no disruption to your workflow.

Read more about 👉 https://hubs.ly/Q048zJnj0

27/03/2026

Rosa Maria Bruno is a physician, researcher and professor of clinical pharmacology, as well as a member of the European Society of Cardiology Council on Hypertension, whose work focuses on cardiovascular prevention, vascular ageing and the non-invasive assessment of arterial health. Her research explores how vascular biomarkers such as arterial stiffness and pulse wave velocity can support earlier cardiovascular risk detection and better patient care.

🔹 At MESI Conference 2026, she will speak in RE:THINK Technology pannel with her session: Arterial stiffness: The missing piece in vascular assessment.

Join us in Bled to hear her perspective on the role of vascular insights in modern diagnostics.

📍 Bled, Slovenia
📅 18–19 May 2026

Register here: https://hubs.ly/Q048zYbn0

26/03/2026

Early PAD detection is vital

Peripheral arterial disease often remains undiagnosed, until it becomes critical. Measuring the Ankle-Brachial Index (ABI) is a fast, guideline-recommended way to detect arterial obstruction early and support timely intervention.

With automated ABI on the MESI mTABLET, clinicians can obtain objective, reproducible results in just minutes, without Doppler probes or complex manual calculations.

✔ SmartArm™ detection
✔ Automated ABI device
✔ Pulse waveforms and oscilation graphs
✔ Advanced review and alerts

Early detection changes outcomes. Make ABI part of your everyday workflow. Find out more 👉https://hubs.ly/Q0448jn70

25/03/2026

Meet Sven Jungmann, MD, PhD at MESI Conference 2026

Known as the “Big Data Doctor,” Sven Jungmann works at the intersection of medicine, data and digital health. His work explores how technology and data-driven tools are transforming clinical decision-making, workflows and the future of healthcare.

🔹 At MESI Conference 2026, he will join RE:THINK Technology with his session:
Rethinking diagnostic pathways in modern healthcare.

If you are interested in how diagnostics, data and innovation come together in real practice, this is a session not to miss.

📍 Bled, Slovenia
📅 18–19 May 2026

Register here: https://hubs.ly/Q047Tz_K0

24/03/2026

🩺 Peripheral Arterial Disease (PAD) remains one of the most underdiagnosed manifestations of systemic atherosclerosis, despite its strong association with adverse cardiovascular events.

For clinicians, this is a critical point:
▪️ PAD is not “just” a peripheral circulation issue, it is a marker of high overall cardiovascular risk.
▪️ Many patients are asymptomatic or present with atypical leg symptoms.

PAD is frequently identified late, sometimes only after significant vascular compromise has already occurred.

Early detection through simple, non-invasive assessment with Ankle-Brachial Index (ABI) allows timely intervention, optimization of secondary prevention strategies, and better long-term outcomes.

If we want to reduce cardiovascular morbidity and mortality, PAD screening must become a standard part of risk assessment in primary care and specialist settings alike.

Insights from Dr. Jean-Pierre Laroche, MD, a specialist in Vascular Medicine at the Hospital Center University of Montpellier, France reinforce the importance of systematic PAD assessment as part of comprehensive cardiovascular risk evaluation.

Read more here: 👉https://hubs.ly/Q045kt8v0

23/03/2026

18–19 May 2026 | Bled, Slovenia
For the first time, we are revealing the full program of MESI Conference 2026💙!

Built around the umbrella topic RE:DIAGNOSE with Integrated Diagnostic Solutions, this year’s conference brings together four connected perspectives:

🔹 RE:THINK Technology
🔹 RE:DEFINE Workflows
🔹 RE:SET Outcomes with Integrated Diagnostics
🔹 RE:CONNECT People and Care

From leading KOLs and practical workshops to Sales Skills Lab, Interactive corners, business meetings and memorable evenings in Bled, the program is designed to connect ideas, people and real-world practice.

Explore the full programme here: https://hubs.ly/Q047TFz60

📍 Bled, Slovenia
📅 18–19 May 2026

22/03/2026

From fragmented to connected

MESI mTABLET replaces disconnected diagnostic tools with one integrated, user-friendly solution - combining wireless modules, patient data, clinical support, and seamless EHR connectivity. Built-in workflows reduce admin work and ensure consistent, efficient exams.

MESI mTABLET. Designed for faster and smarter care.
✔️ Integrated diagnostic modules
✔️ Integrated for better collaboration
✔️ Integrated into every workflow
✔️ Integrated with EHR

Read more about 👉 https://hubs.ly/Q0448gK50

21/03/2026

Masked peripheral arterial disease: a hidden risk

Peripheral arterial disease (PAD) is a major cardiovascular risk factor, but some cases remain “masked,” presenting with normal blood pressure readings and subtle symptoms. These hidden cases often go undetected, putting patients at higher risk of heart attack, stroke, and other complications.

Prof. Tristan Mirault from Paris Cité University emphasizes the importance of identifying risk groups, such as older adults, patients with diabetes, and those with a history of cardiovascular disease, and using reliable diagnostic tools for early detection. https://hubs.ly/Q046VT0L0

Early recognition of masked PAD enables timely interventions, improves patient outcomes, and helps clinicians provide truly proactive care.

Discover more about how to identify masked PAD and its implications for clinical practice 👉https://hubs.ly/Q046VXy80